ELUT Q1 2025 Earnings — Elutia Inc. Revenue & Financial Results | Market Cap Arena

ELUTElutia Inc.

$48M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M-9.9% YoY

Gross Profit

$2M40.7% margin

Operating Income

-$8M-131.4% margin

Net Income

-$4M-65.2% margin

EPS (Diluted)

$-0.21

QoQ Revenue Growth

+10.3%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$39M

Total Liabilities

$76M

Stockholders' Equity

-$36M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$7M	-9.9%
Gross Profit	$2M	$3M	-13.6%
Operating Income	-$8M	-$8M	+6.6%
Net Income	-$4M	-$18M	+78.1%

Revenue Segments

Women's Health

$3M89%

Cardiovascular

$326,00011%